Asked recently for an update, DEA spokesperson Rusty Payne told VICE News, "We don't have a timeline on the decision."
The attorney general and DEA have the final say on rescheduling, but the
FDA offered its official stance on the issue at least eight months ago,
according to the agencies' joint letter to members Congress, which said
the DEA received the FDA's input sometime prior to September 30, 2015.
Neither agency, however, is currently willing to reveal what the FDA
thinks ought to happen.
Article here (via VICE News.)
No comments:
Post a Comment